Market revenue in 2023 | USD 67.8 million |
Market revenue in 2030 | USD 99.2 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Molecular diagnostics |
Fastest growing segment | Immunoassays |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy |
Key market players worldwide | Quest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 25.37% in 2023. Horizon Databook has segmented the Sweden laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.
LDT market is rapidly evolving, and new trends & developments are emerging continuously in the country. Some of the factors contributing to the market growth include advancements in technology, increasing demand for personalized medicine, and changes in regulatory practices.
Furthermore, companies operating in the market include Roche, Qiagen, Immunovia AB, Hologic, and others. Immunovia AB offers a IMMray PanCan-d, a blood test for the detection of pancreatic cancer. Moreover, in August 2021, the company announced commercializing this product as LDT in the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into Sweden laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account